Hologic Inc. logo

Hologic Inc. (HOLX)

Delisted
7 Apr 2026
NASDAQ (NGS) NASDAQ (NGS)
$
76. 01
0
0%
$
16.97B Market Cap
38.79 P/E Ratio
- Div Yield
101.96M Volume
3.91 Eps
$ 76.01
Previous Close
Day Range
76.01 76.01
Year Range
51.9 76.07
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HOLX or IDXX: Which Is the Better Value Stock Right Now?

HOLX or IDXX: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?

Zacks | 7 months ago
Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings

Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings

HOLX's fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.

Zacks | 7 months ago
Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

The maker of women's health products rejected a $16 billion offer from the parties in May.

Barrons | 7 months ago
Why the Market Dipped But Hologic (HOLX) Gained Today

Why the Market Dipped But Hologic (HOLX) Gained Today

Hologic (HOLX) reached $68.5 at the closing of the latest trading day, reflecting a +2.24% change compared to its last close.

Zacks | 7 months ago
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.

Zacks | 7 months ago
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation

Hologic Expands Panther Fusion's Menu With Diagnostic Innovation

HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.

Zacks | 7 months ago
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests

HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests

Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.

Zacks | 8 months ago
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum

Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum

HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.

Zacks | 8 months ago
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Zacks | 8 months ago
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?

HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?

Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.

Zacks | 8 months ago
Hologic's Strong International Traction to Continue Despite Headwinds

Hologic's Strong International Traction to Continue Despite Headwinds

HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.

Zacks | 8 months ago
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 8 months ago
Loading...
Load More